Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Itraconazole effectively treats scalp fungus, with continuous use more effective than pulse therapy.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Biotin supplements increased biotin levels but did not significantly prevent hair loss in rats on valproic acid.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Sonidegib and vismodegib have different side effects and reporting patterns.

STS01 1% effectively promotes hair regrowth with minimal side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Upadacitinib improved multiple immune-related conditions in one patient.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Stopping valproate and using lactulose can quickly treat valproate-induced hyperammonemia.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Biotin supplements did not significantly reduce hair loss in rats on valproic acid.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

An arthritis drug helped a person with severe hair loss regrow their hair.